PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Protein Folding and Misfolding: It's the Journey, Not the Destination
March 2015
CCR5 and HIV Infection
January 2015
HIV/AIDS: Pre-fusion Env Exposed
January 2015
HIV/AIDS: Slide to Enter
January 2015
Updating ModBase
January 2015
Power in Numbers
August 2014
Quorum Sensing: A Groovy New Component
August 2014
Bacterial CDI Toxins
June 2014
Immunity: One Antibody to Rule Them All
June 2014
Virology: A Bat Influenza Hemagglutinin
March 2014
Virology: Making Sensitive Magic
March 2014
Virology: Visualizing Cyanophage Assembly
March 2014
Virology: Zeroing in on HBV Egress
March 2014
Viroporins
March 2014
Cas4 Nuclease and Bacterial Immunity
February 2014
Microbial Pathogenesis: A GNAT from Pseudomonas
February 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Microbiome: The Dynamics of Infection
September 2013
Membrane Proteome: A Funnel-like Viroporin
August 2013
Infectious Diseases: A Pathogen Ubiquitin Ligase
May 2013
Infectious Diseases: A Shared Syringe
May 2013
Infectious Diseases: Determining the Essential Structome
May 2013
Infectious Diseases: Targeting Meningitis
May 2013
NDM-1 and Antibiotics
May 2013
Bacterial Hemophores
January 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Microbial Pathogenesis: NEAT Iron
January 2013
Membrane Proteome: Sphingolipid Synthesis Selectivity
December 2012
A signal sensing switch
September 2012
Gauging needle structure
July 2012
Anthrax Stealth Siderophores
June 2012
A Pseudomonas L-serine dehydrogenase
May 2012
Pilus Assembly Protein TadZ
April 2012
Making Lipopolysaccharide
January 2012
Superbugs and Antibiotic Resistance
December 2011
A change to resistance
November 2011
An effective and cooperative dimer
November 2011
The Perils of Protein Secretion
November 2011
Bacterial Armor
October 2011
Breaking down the defenses
September 2011
Moving some metal
August 2011
Capsid assembly in motion
April 2011
Know thy enemy … structurally
October 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Hemolysin BL
January 2010
Unusual cell division
October 2009
Anthrax evasion tactics
September 2009
Toxin-antitoxin VapBC-5
September 2009
Antibiotic target
August 2009
Lysostaphin
July 2009
Tackling influenza
June 2009
You look familiar: the Type VI secretion system
June 2009
Unique SARS
April 2009
Anthrax stealth molecule
March 2009
A new class of bacterial E3 ubiquitination enzymes
January 2009
Antiviral evasion
October 2008
SARS connections
September 2008
SARS Coronavirus Nonstructural Protein 1
June 2008

Research Themes Infectious diseases

Infectious Diseases: A Pathogen Ubiquitin Ligase

SBKB [doi:10.1038/sbkb.2012.139]
Featured Article - May 2013
Short description: A novel bacterial effector protein functions as a ubiquitin E3 ligase.

Ribbon diagram and surface of XopL XL-box structure. Residues critical for interaction with plant E2 enzyme and the N- and C-termini are in blue. Figure courtesy of Alexei Savchenko and Ullas Bonas.

The type III secretion system (T3SS) is used by most Gram-negative pathogenic bacteria to inject effector proteins directly into host cells, where they manipulate diverse cellular processes and suppress host immune responses. Despite key roles in infection, the biochemical mechanisms employed by the majority of bacterial effectors remain unknown.

Bonas, Savchenko and colleagues (MLU Halle Dept. of Genetics and PSI MCSG Toronto) have recently identified Xanthomonas outer protein L (XopL) as a T3SS effector from X. campestris, a model plant pathogen. Initially identified by a genome search, the protein contains leucine-rich repeats (LRRs), which are typically found only in eukaryotic proteins. Since several LRR-containing effectors from animal pathogens can function as ubiquitin ligases, the authors tested XopL and found that it functions as a robust and specific E3 ubiquitin ligase, mediating the transfer of ubiquitin from plant E2 conjugating enzymes.

Ubiquitination requires the C-terminal domain of XopL, a region that lacks any homology to known E3 ligases, prompting the authors to determine the crystal structures of fragments of XopL using single-wavelength anomalous dispersion data. The N-terminal domain, solved to 2.0 Å (PDB 4FCG), adopts a canonical LRR architecture containing a consensus sequence similar to plant LRR-containing proteins. Unexpectedly, the LRR domain alone is sufficient to suppress plant immunity responses.

The C-terminal domain, solved to 1.8 Å (PDB 4FC9), is composed of a four-helix bundle with no structural homology to E3 ligases or other proteins. This domain, termed XL-box, folds into two lobes surrounding a negatively charged cleft harboring conserved residues. Since the XL-box lacks cysteine residues, the E3 ligase activity of XopL apparently does not involve thioester intermediates as for eukaryotic (HECT-type) and other effector E3 ligases. The authors propose that XopL could transfer ubiquitin directly from cognate E2 to substrates, using a mechanism similar to that of RING/U-box E3 ligases. While mutational analysis identified residues involved in E2 complex formation, the unique XL-box domain structure necessitates the identification of interacting host factors and structural analysis of an E2-E3 complex to elucidate the transfer mechanism.

Michael A. Durney

References

  1. A.U. Singer et al. A pathogen type III effector with a novel E3 ubiquitin ligase architecture.
    PLoS Pathog. 9, e1003121 (2013). doi:10.1371/journal.ppat.1003121

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health